PMID- 25002392 OWN - NLM STAT- MEDLINE DCOM- 20150413 LR - 20140708 IS - 1522-6662 (Electronic) IS - 1098-3511 (Linking) VI - 17 IP - 3 DP - 2014 Jun TI - Efficacy of near-infrared spectrometry for monitoring the cerebral effects of severe dilutional anemia. PG - E154-9 LID - 10.1532/HSF98.2013293 [doi] AB - INTRODUCTION: Clear guidelines for red cell transfusion during cardiac surgery have not yet been established. The current focus on blood conservation during cardiac surgery has increased the urgency to determine the minimum safe hematocrit for these patients. The aim of this study was to determine whether monitoring of cerebral regional oxygen saturation (rSO2) via near-infrared spectrometry (NIRS) is effective for assessing the cerebral effects of severe dilutional anemia during elective coronary arterial bypass graft surgery (CABG). METHODS: The prospective observational study involved patients who underwent cerebral rSO2 monitoring by NIRS during elective isolated first-time CABG: an anemic group (N=15) (minimum Hemoglobin (Hb) <7 g/dL at any period during cardiopulmonary bypass (CPB) and a control group (N=15) (Hb >8 g/dL during CPB). Mean arterial pressure (MAP), pump blood flow, blood lactate level, pCO2, pO2 at five time points and cross-clamp time, extracorporeal circulation time were recorded for each patient. Group results statistically were compared. RESULTS: The anemic group had significantly lower mean preoperative Hb than the control group (10.3 mg/dL versus 14.2 mg/dL; P = .001). The lowest Hb levels were observed in the hypothermic period of CPB in the anemic group. None of the controls exhibited a >20% decrease in cerebral rSO2. Eleven (73.3%) of the anemic patients required an increase in pump blood flow to raise their cerebral rSO2. CONCLUSIONS: In this study, the changes in cerebral rSO2 in the patients with low Hb were within acceptable limits, and this was in concordance with the blood lactate levels and blood-gas analysis. It can be suggested that NIRS monitoring of cerebral rSO2 can assist in decision making related to blood transfusion and dilutional anemia during CPB. FAU - Cem, Ariturk AU - Cem A AD - Department of Cardiovascular Surgery, Acibadem University School of Medicine, Atasehir, Istanbul, Turkey. FAU - Serpil, Ustalar Ozgen Zehra AU - Serpil UO AD - Department of Anesthesiology and Reanimation, Acibadem University School of Medicine, Atasehir, Istanbul, Turkey. FAU - Fevzi, Toraman AU - Fevzi T AD - Department of Anesthesiology and Reanimation, Acibadem University School of Medicine, Atasehir, Istanbul, Turkey. FAU - Murat, Okten AU - Murat O AD - Department of Cardiovascular Surgery, Acibadem University School of Medicine, Atasehir, Istanbul, Turkey. FAU - Umit, Gullu AU - Umit G AD - Department of Cardiovascular Surgery, Acibadem University School of Medicine, Atasehir, Istanbul, Turkey. FAU - Esin, Erkek AU - Esin E AD - Department of Cardiovascular Surgery, Acibadem Healthcare Group, Acibadem Kadikoy Hospital, Kadikoy, Istanbul, Turkey. FAU - Pinar, Uysal AU - Pinar U AD - Department of Cardiovascular Surgery, Acibadem Healthcare Group, Acibadem Kadikoy Hospital, Kadikoy, Istanbul, Turkey. FAU - Sahin, Sensy AU - Sahin S AD - Department of Cardiovascular Surgery, Acibadem University School of Medicine, Atasehir, Istanbul, Turkey. FAU - Hasan, Karabulut AU - Hasan K AD - Department of Cardiovascular Surgery, Acibadem University School of Medicine, Atasehir, Istanbul, Turkey. FAU - Cem, Alhan AU - Cem A AD - Department of Cardiovascular Surgery, Acibadem University School of Medicine, Atasehir, Istanbul, Turkey. LA - eng PT - Comparative Study PT - Journal Article PT - Observational Study PL - United States TA - Heart Surg Forum JT - The heart surgery forum JID - 100891112 RN - S88TT14065 (Oxygen) SB - IM MH - Anemia/diagnosis/etiology/*prevention & control MH - Brain/*metabolism MH - Coronary Artery Bypass/*adverse effects MH - Erythrocyte Transfusion/*methods MH - Female MH - Humans MH - Male MH - Middle Aged MH - Monitoring, Intraoperative/*methods MH - Oximetry/methods MH - Oxygen/*metabolism MH - Prospective Studies MH - Reproducibility of Results MH - Sensitivity and Specificity MH - Spectroscopy, Near-Infrared/*methods MH - Treatment Outcome EDAT- 2014/07/09 06:00 MHDA- 2015/04/14 06:00 CRDT- 2014/07/09 06:00 PHST- 2014/07/09 06:00 [entrez] PHST- 2014/07/09 06:00 [pubmed] PHST- 2015/04/14 06:00 [medline] AID - 62022775T62312H4 [pii] AID - 10.1532/HSF98.2013293 [doi] PST - ppublish SO - Heart Surg Forum. 2014 Jun;17(3):E154-9. doi: 10.1532/HSF98.2013293.